Skip to main content
FinSpry Logo
FinSpry
IPHA logo
IPHA
(NASDAQ)
Innate Pharma S.A.
$1.37-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Innate Pharma (IPHA) Stock Price & Financial Analysis

Innate Pharma Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.33 - $1.40
52-Week High$2.63
52-Week Low$1.17
Open$1.33
Volume17.25K
Average Volume (3M)17.25K
Market Cap119.10M
Shares Outstanding86.94M
Price to Sales (P/S)2.99
Price to Book (P/B)19.78
EV/EBITDA-0.91
Revenue (TTM)39.22M
Net Income (TTM)-92.29M
Free Cash Flow (TTM)-68.80M
EPS (TTM)$-1.06
Profit Margin-235.33%
Operating Margin-248.01%
Return on Equity (ROE)-1557.21%
Debt to Equity5.25
50-Day MA$1.59
200-Day MA$1.86
52-Week Change-29.32%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Innate Pharma

What is the current stock price for IPHA?

As of the latest trading session, IPHA stock trades at $1.37. The 52-week range is $1.17–$2.63, with a day range of $1.33–$1.40.

What is the P/E ratio for IPHA?

The P/E ratio (Price-to-Earnings) for IPHA is shown in the Key Statistics section. This valuation metric helps compare Innate Pharma S.A. to industry peers.

Does IPHA pay dividends?

Innate Pharma does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for IPHA?

Based on 1 analyst, the consensus for IPHA is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of IPHA?

Innate Pharma's market capitalization is $119.1M, classifying it as a micro-cap company. Innate Pharma operates in the Healthcare sector within the Biotechnology industry.